Weekly News Digest: August 13, 2021
Welcome to the Weekly News Digest presented by Marry Jane! Today, we will be featuring seven hot news items from the CBD and CBD-related world. In other words, everything you are probably already interested in if you are planning to or already are consuming CBD products. Here we go!
1. Gibraltar is preparing legislation allowing for the import, export, production and supply of medical cannabis
Today, we are starting in the southern tip of the European continent, Gibraltar. The territory’s Minister of Public Health has announced to parliament that the government will soon publish legislation to create a well-regulated medical cannabis industry in Gibraltar. This legislation will regulate the production, import, export, marketing and supply of cannabis for medical and related purposes, including the creation of quality jobs.
2. Idaho says it’s ready to submit cannabis programme to USDA soon
Crossing the Atlantic Ocean, we move to the United States. According to the Idaho Department of Agriculture (ISDA), the state could begin accepting hemp licence applications by the middle of October, and planting could begin next spring. In April, Governor Brad Little signed into law the state’s hemp law, legalising the production, sale and processing of industrial hemp under ISDA regulations. Licences will be offered to producers and processors. CBD is illegal under the provisions of the law. By the way, Idaho is the last of the US states to establish a cannabis programme.
3. State of Washington will certify extracts produced for sale in other states
The Department of Agriculture in Washington State will begin certifying cannabis extracts. Under the new programme, processors who wish to produce hemp extracts for use as a food ingredient can apply for a hemp extract certificate, which guarantees compliance with Washington’s inspection and good manufacturing practices requirements. But these products can only be sold outside the state. CBD and other hemp extracts are banned as dietary supplements in Washington but may be marketed in interstate commerce.
4. Brazilian congressman calls for legislation on industrial hemp and medical cannabis to stimulate economy
We now move south. During a seminar on the present and future challenges of the regulatory framework for medicinal cannabis hosted by the Brazilian Bar Association, Brazilian Congressman João Carlos Bacelar Batista reiterated the importance of hemp regulation in the country. “It is necessary for the economy and health of Brazil. Let’s defeat the opponents and show that we can only win,” the congressman said. He also mentioned that industrial hemp is not psychotropic, and has thousands of uses in a variety of industries such as pharmaceuticals, textiles, recycling, automotive, food and beverage, civil engineering and agribusiness.
5. Paraguay becomes first country from Latin America to export organic hemp seeds to Europe
20 tonnes of certified organic hemp seeds grown in Paraguay during the 2020-2021 summer growing season have been exported to the European Union. It is believed that Paraguay is the third country to export hemp seeds to the European Union, after Canada and China.
6. Cannabis decriminalisation bill fails to win majority support in Israeli parliament
A bill to decriminalise recreational use of up to 50 grams and 15 seeds of cannabis for personal use, and to reclassify CBD as a dietary supplement, failed to win the majority of votes in Israel’s parliament (Knesset). The bill that had been tabled failed to pass with 52 votes to 55. Failure to pass the bill means the coalition will have to wait another six months before it can try again to bring it to the Knesset plenum for a second vote.
7. Australia conducts study on entourage effect of cannabis
And we would like to finish today’s edition with some scientific news. Sydney University’s Lambert Initiative for Cannabinoid Therapeutics has conducted research showing that hemp extracts can deliver high concentrations of cannabinoid acids to mice via a “pharmacokinetic environment” mechanism. This is higher than when they are administered alone as a single molecule. The extract delivered 14 times higher concentrations of cannabidiolic acid (CBDA) into the bloodstream after oral administration to mice. The lead author of the study, Dr Lyndsey Anderson, said: “This result provides us with a pathway to explore why some cannabis extracts yield pharmacological effects in humans at lower doses”.
Our Weekly News Digest for today has come to an end. Keep following our blog for more engaging interviews, informative articles and news digests. Have a great weekend and stay safe!